Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Letrozole|DRUG: Afatinib
Sponsor: Translational Research in Oncology
Collaborators: Boehringer Ingelheim